Mabala, Cristina C.

HRN: 22-59-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2023
CEFUROXIME 1.5GM (VIAL)
10/11/2023
10/11/2023
IV
1.5 Grams
Q8
For Stat CS
Waiting Final Action 
10/11/2023
CEFUROXIME 500MG (TAB)
10/11/2023
10/12/2023
PO
500mg
BID
S/p NSVD W/ Perineal Laceration
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: